Clinical trial · Observational
H19 in Acute Lymphoblastic Leukemia.
Expression of Long Non-Coding RNA H19 in Acute Lymphoblastic Leukemia
NCT05943093CI-TRIAL-00067981unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
* Study the expression level of H19 gene in the samples from ALL patients by real-time PCR. * Correlate the expression level of H19 gene with the clinical presentation and laboratory data of those patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Lymphoid Leukemia | Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- ALL patients
- label
- control group free from the disease
Primary outcomes (1)
- measure
- - Study the expression level of H19 gene in the samples from ALL patients by real-time PCR.
- timeFrame
- baseline
Secondary outcomes (1)
- measure
- Correlate the expression level of H19 gene with the clinical presentation and laboratory data of those patients.
- timeFrame
- baseline
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 2 Months
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Newly diagnosed ALL patients. Exclusion Criteria: \- 1-Presence of other haematological disorders, history of other malignancies or relapsed ALL. 2-Patients under chemotherapy or radiotherapy.
References
Publications (0)
Data not yet available
No reference posted for this study.